x
 
 
 
 

About Us

Leadership Team

photo team

Xavier Barril, Ph.D.

Chief Scientific Officer

Dr. Xavier Barril has served as chief scientific officer since January 2018. Dr. Barril has over 18 years of experience in computational chemistry and drug discovery. Since 2005, Dr. Barril has been with University of Barcelona as ICREA professor. Prior to joining Gain, Dr. Barril served as co-founder & scientific advisor to Minoryx Therapeutics. He has also developed his career at Vernalis as a senior investigator. Among other discoveries, Dr. Barril is co-inventor of the Hsp90 inhibitors that Vernalis licensed to Novartis and which underwent clinical trials. He is the inventor of the innovative platform technology that Gain Therapeutics is exploiting to identify new structurally targeted allosteric regulators. Dr. Barril has co-authored more than 80 scientific publications and 10 patents. Dr. Barril received a Ph.D. in Biochemistry from the University of Barcelona.

 

 
 
 

Research and Development Collaborations

lilly 

 

Grants

Grants Grants Grants Grants

 

Patient Associations

Patient Associations Patient Associations Patient Associations Patient Associations

Centers of Research, Translational Science & Clinical Excellence

Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research
Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research
 

Interested in working with a dynamic team of research,
medical and business professionals? 

View Job opportunities